August 19, 2009 12:08 PM
- Text
Zyrtec and Claritin's New Eye Drops Contain Neither Zyrtec Nor Claritin
(MoneyWatch) There's a strange war brewing between Johnson & Johnson's McNeil Consumer Healthcare unit and Schering-Plough over their monster allergy brands Zyrtec and Claritin.
Both companies have extended their brands into new eye-drops products, but despite carrying the Zyrtec and Claritin names neither eye-drops brand contains any of the drugs that consumers know as Zyrtec or Claritin.
The drug in Schering's Claritin pills is loratadine, but Claritin Eye contains ketotifen, not loratadine. The drug in McNeil's Zyrtec pills is cetirizine, but Zyrtec Itchy Eye Drops contains ketotifen fumarate, not cetirizine. A note on the Zyrtec web site says:
The Claritin web site only distinguishes the products when you click to look at the ingredients label.
Messages left for McNeil and Schering were not immediately returned. The obvious question: Was it a good idea for the FDA to approve two different drugs under the same name?
Disclosure: The author is a longtime Claritin user.
Both companies have extended their brands into new eye-drops products, but despite carrying the Zyrtec and Claritin names neither eye-drops brand contains any of the drugs that consumers know as Zyrtec or Claritin.The drug in Schering's Claritin pills is loratadine, but Claritin Eye contains ketotifen, not loratadine. The drug in McNeil's Zyrtec pills is cetirizine, but Zyrtec Itchy Eye Drops contains ketotifen fumarate, not cetirizine. A note on the Zyrtec web site says:
The ingredients and uses of this product are different than other ZYRTEC products.
The Claritin web site only distinguishes the products when you click to look at the ingredients label.Messages left for McNeil and Schering were not immediately returned. The obvious question: Was it a good idea for the FDA to approve two different drugs under the same name?
Disclosure: The author is a longtime Claritin user.
Latest Now in MoneyWatch
- Big banks, gov't officials strike $25B deal
- LinkedIn swings back to profit
- LinkedIn doubles revenue, beats growth estimates
- Kodak to stop making digital cameras, frames
- Market cap, schmarket cap, Apple still gets no respect
- Philip Morris Int'l income up nearly 8 percent
- Survey: Small biz plans big hires in 2012
- Freddie Mac: Mortgages inch higher but stay low
- Will the European debt crisis sink Obama's re-election?
- Banks in $25B deal to settle foreclosure abuses
- Joe Coffee: Scaling up without selling your soul
- Greek agreement accomplishes nothing
- 401K plans: New rules make costs clearer
- Are women leaders selling themselves short?
- Ask the Experts: New 401(k) rules
- Mortgage lenders strike a deal
- $25B foreclosure-abuse settlement reached
Latest CBS News Headlines
on Facebook
on CBS News
- Man accused of threatening Obama charged again
- NY Fashion Week: Wearable, sellable style for fall
- On the Call: LinkedIn CFO Steve Sordello
- Guilty plea anticipated in NY baby kidnap case
on Facebook
- Adele opens up about vocal cord surgery
- Tenn. father charged with murdering couple who"unfriended" daughter on Facebook
- Mo. teen gets life in prison for murder of 9-year-old girl
on CBS News






